4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)

CUSIP: 35104E100

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
51,571,939
Total 13F shares
30,404,028
Share change
+2,404,067
Total reported value
$522,337,328
Put/Call ratio
135%
Price per share
$17.19
Number of holders
94
Value change
+$34,968,755
Number of buys
52
Number of sells
39

Security key

35104E100

Report period

Q1 2023

Institutions

94

Top holders

10

Top shareholders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BVF INC/IL
13F
Company
7.8%
4,007,413
$89,004,643 31 Dec 2022
13F
VIKING GLOBAL INVESTORS LP
13F
Company
7.6%
3,937,914
$87,461,070 31 Dec 2022
13F
Deep Track Capital, LP
13F
Company
5.2%
2,656,901
$59,009,771 31 Dec 2022
13F
BlackRock Finance, Inc.
13F
Company
4.9%
2,508,632
$55,716,718 31 Dec 2022
13F
JANUS HENDERSON GROUP PLC
13F
Company
2.8%
1,466,267
$32,562,787 31 Dec 2022
13F
MORGAN STANLEY
13F
Company
2.8%
1,458,572
$32,394,883 31 Dec 2022
13F
VANGUARD GROUP INC
13F
Company
2.5%
1,272,210
$28,255,785 31 Dec 2022
13F
STATE STREET CORP
13F
Company
2.4%
1,235,158
$27,432,859 31 Dec 2022
13F
ArrowMark Colorado Holdings LLC
13F
Company
1.9%
982,199
$21,814,640 31 Dec 2022
13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
13F
Company
1.5%
773,600
$17,181,656 31 Dec 2022
13F
Casdin Capital, LLC
13F
Company
1.2%
630,000
$13,992,300 31 Dec 2022
13F
Commodore Capital LP
13F
Company
1.2%
598,385
$13,290,000 31 Dec 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.1%
561,737
$12,476,000 31 Dec 2022
13F
Octagon Capital Advisors LP
13F
Company
0.97%
499,996
$11,104,911 31 Dec 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.85%
439,974
$9,772,000 31 Dec 2022
13F
Eagle Health Investments LP
13F
Company
0.85%
437,911
$9,726,003 31 Dec 2022
13F
Opaleye Management Inc.
13F
Company
0.64%
330,000
$7,329,300 31 Dec 2022
13F
NORGES BANK
13F
Company
0.57%
294,000
$6,529,740 31 Dec 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.56%
287,483
$6,385,000 31 Dec 2022
13F
NORTHERN TRUST CORP
13F
Company
0.53%
274,821
$6,103,774 31 Dec 2022
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.51%
260,704
$5,790,235 31 Dec 2022
13F
Soleus Capital Management, L.P.
13F
Company
0.49%
254,700
$5,656,887 31 Dec 2022
13F
Perigon Wealth Management, LLC
13F
Company
0.48%
246,075
$5,465,326 31 Dec 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.42%
216,900
$4,817,349 31 Dec 2022
13F
Invesco Ltd.
13F
Company
0.38%
196,201
$4,357,624 31 Dec 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
0.37%
189,389
$4,206,330 31 Dec 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.3%
153,974
$3,419,763 31 Dec 2022
13F
Point72 Asset Management, L.P.
13F
Company
0.27%
139,300
$3,093,853 31 Dec 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.25%
129,097
$2,867,000 31 Dec 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.25%
128,100
$2,845,000 31 Dec 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.23%
118,344
$2,628,420 31 Dec 2022
13F
Bank of New York Mellon Corp
13F
Company
0.21%
109,910
$2,441,101 31 Dec 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.15%
77,412
$1,719,320 31 Dec 2022
13F
DEUTSCHE BANK AG\
13F
Company
0.15%
74,969
$1,665,061 31 Dec 2022
13F
MARSHALL WACE, LLP
13F
Company
0.14%
69,747
$1,549,080 31 Dec 2022
13F
Squarepoint Ops LLC
13F
Company
0.12%
62,126
$1,379,818 31 Dec 2022
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
0.1%
53,836
$1,195,698 31 Dec 2022
13F
Vontobel Holding Ltd.
13F
Company
0.1%
53,836
$1,195,698 31 Dec 2022
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.09%
48,198
$1,070,478 31 Dec 2022
13F
Rafferty Asset Management, LLC
13F
Company
0.09%
47,933
$1,064,592 31 Dec 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.09%
47,443
$1,054,000 31 Dec 2022
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.08%
42,400
$941,704 31 Dec 2022
13F
UBS Group AG
13F
Company
0.08%
40,728
$904,569 31 Dec 2022
13F
Peloton Wealth Strategists
13F
Company
0.07%
37,000
$822,000 31 Dec 2022
13F
JANE STREET GROUP, LLC
13F
Company
0.07%
36,306
$806,356 31 Dec 2022
13F
BARCLAYS PLC
13F
Company
0.07%
34,673
$770,086 31 Dec 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.06%
32,226
$715,739 31 Dec 2022
13F
FMR LLC
13F
Company
0.05%
26,902
$597,493 31 Dec 2022
13F
CITIGROUP INC
13F
Company
0.05%
25,816
$573,373 31 Dec 2022
13F
M&T BANK CORP
13F
Company
0.05%
23,544
$522,456 31 Dec 2022
13F

Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT) as of Q1 2023

As of 31 Mar 2023, 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT) was held by 94 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,404,028 shares. The largest 10 holders included BVF INC/IL, VIKING GLOBAL INVESTORS LP, BlackRock Inc., Deep Track Capital, LP, STATE STREET CORP, JANUS HENDERSON GROUP PLC, MORGAN STANLEY, VANGUARD GROUP INC, Casdin Capital, LLC, and ArrowMark Colorado Holdings LLC. This page lists 94 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders
97
Q1 2023 holders
94
Holder diff
-3
Investor Q4 2022 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2022 Value $ Q1 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .